A randomized, open-label non-inferiority study to compare palonosetron and ondansetron for prevention of acute chemotherapy-induced vomiting in children with cancer receiving moderate or high…

Overview of attention for article published in Supportive Care in Cancer, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 1 news outlet

policy: 1 policy source

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 34 Mendeley

Summary News Policy documents Dimensions citations

So far, Altmetric has seen 1 news story.

Palonosetron Noninferior to Ondansetron for Pediatric Chemotherapy-induced Vomiting

Oncology Nurse Advisor , 26 Mar 2018

March 26, 2018 Ondansetron is currently a mainstay of CIV management but has limitations.